Literature DB >> 2474672

Identification of amino acids recognized by syncytium-inhibiting and neutralizing monoclonal antibodies to the human parainfluenza type 3 virus fusion protein.

K V Coelingh1, E L Tierney.   

Abstract

Neutralizing monoclonal antibodies specific for the fusion (F) glycoprotein of human parainfluenza type 3 virus (PIV3) were used to select neutralization-resistant antigenic variants. Sequence analysis of the F genes of the variants indicated that their resistance to antibody binding, antibody-mediated neutralization or to both was a result of specific amino acid substitutions within the neutralization epitopes of the F1 and F2 subunits. Comparison of the locations of PIV3 neutralization epitopes with those of Newcastle disease and Sendai viruses indicated that the antigenic organization of the fusion proteins of paramyxoviruses is similar. Furthermore, some of the PIV3 epitopes recognized by syncytium-inhibiting monoclonal antibodies are located in an F1 cysteine cluster region which corresponds to an area of the measles virus F protein involved in fusion activity.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2474672      PMCID: PMC250967     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  23 in total

1.  Antigenic variation in the hemagglutinin-neuraminidase protein of human parainfluenza type 3 virus.

Authors:  K L van Wyke Coelingh; C Winter; B R Murphy
Journal:  Virology       Date:  1985-06       Impact factor: 3.616

2.  Neutralization of yellow fever virus studied using monoclonal and polyclonal antibodies.

Authors:  A Buckley; E A Gould
Journal:  J Gen Virol       Date:  1985-12       Impact factor: 3.891

3.  Mutations located on both F1 and F2 subunits of the Newcastle disease virus fusion protein confer resistance to neutralization with monoclonal antibodies.

Authors:  C Neyt; J Geliebter; M Slaoui; D Morales; G Meulemans; A Burny
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

4.  Identification of biological activities of paramyxovirus glycoproteins. Activation of cell fusion, hemolysis, and infectivity of proteolytic cleavage of an inactive precursor protein of Sendai virus.

Authors:  A Scheid; P W Choppin
Journal:  Virology       Date:  1974-02       Impact factor: 3.616

5.  Three-dimensional structure of an antigenic mutant of the influenza virus haemagglutinin.

Authors:  M Knossow; R S Daniels; A R Douglas; J J Skehel; D C Wiley
Journal:  Nature       Date:  1984 Oct 18-24       Impact factor: 49.962

6.  Activation of the Sendai virus fusion protein (f) involves a conformational change with exposure of a new hydrophobic region.

Authors:  M Hsu; A Scheid; P W Choppin
Journal:  J Biol Chem       Date:  1981-04-10       Impact factor: 5.157

7.  Specific inhibition of paramyxovirus and myxovirus replication by oligopeptides with amino acid sequences similar to those at the N-termini of the F1 or HA2 viral polypeptides.

Authors:  C D Richardson; A Scheid; P W Choppin
Journal:  Virology       Date:  1980-08       Impact factor: 3.616

8.  Alphavirus neurovirulence: monoclonal antibodies discriminating wild-type from neuroadapted Sindbis virus.

Authors:  J Stanley; S J Cooper; D E Griffin
Journal:  J Virol       Date:  1985-10       Impact factor: 5.103

9.  Acquisition of serum antibodies to specific viral glycoproteins of parainfluenza virus 3 in children.

Authors:  J A Kasel; A L Frank; W A Keitel; L H Taber; W P Glezen
Journal:  J Virol       Date:  1984-12       Impact factor: 5.103

10.  Oligopeptides that specifically inhibit membrane fusion by paramyxoviruses: studies on the site of action.

Authors:  C D Richardson; P W Choppin
Journal:  Virology       Date:  1983-12       Impact factor: 3.616

View more
  6 in total

1.  Contribution of measles virus fusion protein in protective immunity: anti-F monoclonal antibodies neutralize virus infectivity and protect mice against challenge.

Authors:  E Malvoisin; F Wild
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

2.  Antigenic structure of human respiratory syncytial virus fusion glycoprotein.

Authors:  J A López; R Bustos; C Orvell; M Berois; J Arbiza; B García-Barreno; J A Melero
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

3.  Naturally occurring human parainfluenza type 3 viruses exhibit divergence in amino acid sequence of their fusion protein neutralization epitopes and cleavage sites.

Authors:  K V Coelingh; C C Winter
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

4.  Assignment of disulfide bridges in the fusion glycoprotein of Sendai virus.

Authors:  S Iwata; A C Schmidt; K Titani; M Suzuki; H Kido; B Gotoh; M Hamaguchi; Y Nagai
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

5.  Measles virus fusion: role of the cysteine-rich region of the fusion glycoprotein.

Authors:  T F Wild; J Fayolle; P Beauverger; R Buckland
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

6.  Diverse Viruses Require the Calcium Transporter SPCA1 for Maturation and Spread.

Authors:  H-Heinrich Hoffmann; William M Schneider; Vincent A Blomen; Margaret A Scull; Alain Hovnanian; Thijn R Brummelkamp; Charles M Rice
Journal:  Cell Host Microbe       Date:  2017-10-11       Impact factor: 21.023

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.